Statements (71)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:business
|
| gptkbp:acquired_by |
gptkb:Novartis_AG
|
| gptkbp:aims_to |
improve public health
|
| gptkbp:collaborates_with |
research institutions
|
| gptkbp:conducts_research_on |
vaccine efficacy
|
| gptkbp:dedicated_to |
patient safety
immunization awareness |
| gptkbp:develops |
immunization programs
|
| gptkbp:employs |
gptkb:scientists
|
| gptkbp:focuses_on |
vaccine development
vaccine accessibility |
| gptkbp:founded_in |
gptkb:1996
|
| gptkbp:has_achieved |
multiple vaccine approvals
|
| gptkbp:has_collaborated_with |
international health organizations
|
| gptkbp:has_collaborations_with |
non-profit organizations
|
| gptkbp:has_developed |
gptkb:vaccine
therapeutic vaccines adjuvanted vaccines |
| gptkbp:has_established |
partnerships with universities
global distribution networks |
| gptkbp:has_headquarters_in |
gptkb:Switzerland
|
| gptkbp:has_impact_on |
global health
|
| gptkbp:has_part |
manufacturing facilities
vaccine research division |
| gptkbp:has_product |
vaccines
|
| gptkbp:has_received |
awards for excellence
|
| https://www.w3.org/2000/01/rdf-schema#label |
Novartis vaccines business
|
| gptkbp:investment |
gptkb:biotechnology
|
| gptkbp:is_active_in |
emerging markets
|
| gptkbp:is_committed_to |
sustainability
|
| gptkbp:is_engaged_in |
community outreach programs
vaccine education healthcare partnerships vaccine education programs |
| gptkbp:is_focused_on |
preventive medicine
global vaccination efforts vaccine research and development vaccine innovation vaccine affordability |
| gptkbp:is_involved_in |
clinical trials
public health campaigns vaccine research funding vaccine supply chain management vaccine safety monitoring vaccine policy advocacy vaccine distribution logistics vaccine distribution strategies vaccine research collaborations vaccine effectiveness studies vaccine research ethics vaccine technology advancements |
| gptkbp:is_known_for |
high-quality production
|
| gptkbp:is_part_of |
global health initiatives
biopharmaceutical sector global health strategies Novartis portfolio |
| gptkbp:is_recognized_for |
commitment to research
leadership in vaccine development innovation in vaccines |
| gptkbp:is_subject_to |
regulatory approvals
|
| gptkbp:is_supported_by |
gptkb:scientific_research
|
| gptkbp:offers |
consultation services
|
| gptkbp:operates_in |
gptkb:pharmaceuticals
|
| gptkbp:part_of |
gptkb:Novartis
|
| gptkbp:participates_in |
healthcare initiatives
|
| gptkbp:partnership |
government agencies
|
| gptkbp:produces |
vaccines for children
vaccines for adults |
| gptkbp:targets |
infectious diseases
|
| gptkbp:bfsParent |
gptkb:GSK
|
| gptkbp:bfsLayer |
4
|